GREENLAND MINES LTD Interest and Fee Income, Other Loans
GREENLAND MINES LTD (GRML) had Interest and Fee Income, Other Loans of $2.46 thousand as of 2024-09-30, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestAndFeeIncomeOtherLoans · last filed 2025-03-31
- 2024-09-30: Interest and Fee Income, Other Loans $2.46K.
- 2024-06-30: Interest and Fee Income, Other Loans 6 month $2.46K.
- 2023-12-12: Interest and Fee Income, Other Loans $2.46K.
| Period end | Interest and Fee Income, Other Loans | Interest and Fee Income, Other Loans 6 month |
|---|---|---|
| 2024-09-30 | $2.46K 10-K · filed 2025-03-31 | |
| 2024-06-30 | $2.46K 10-Q · filed 2024-11-19 | |
| 2023-12-12 | $2.46K 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |